Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MS | GS |
|---|---|---|
| Price | $196.75 | $922.05 |
| Change today | ▼ 0.83% | ▼ 1.53% |
| Market cap | $309.01B | $268.47B |
| Return, 3 months | -10.0% | -14.0% |
| Return, year to date | +12.7% | +6.4% |
| Return, 1 year | +27.4% | +18.6% |
| P/E (TTM) | 15.9 | 14.2 |
| P/B | 2.9 | 2.4 |
| P/E percentile vs own 5y | 64th | 51st |
| Dividend yield | 2.03% | 1.84% |
| Revenue growth (YoY, latest qtr) | +27.4% | +39.5% |
| Net profit growth (YoY) | +58.1% | +78.0% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 26.8% | 30.3% |
| Return on equity | 19.1% | 18.3% |
| Analyst target vs. price | +24.8% | +30.5% |
| Analyst buy share | 57% | 46% |
| RSI (14) | 36 | 36 |
| 30-day volatility | 24.1% | 27.6% |
| Max drawdown, 1 year | -18.8% | -19.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.